-
Product Insights
Hearing Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Hearing Disorders - Drugs In Development, 2023’, provides an overview of the Hearing Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hearing Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Amyotrophic Lateral Sclerosis Clinical Trials Market Report Overview In total there were 694 clinical trials conducted on Amyotrophic Lateral Sclerosis, as of April 2023.The Amyotrophic Lateral Sclerosis clinical trial market research report provides an overview of the Amyotrophic Lateral Sclerosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Amyotrophic Lateral Sclerosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage...
-
Product Insights
Hypereosinophilic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out. The Hypereosinophilic Syndrome pipeline drugs market research report provides...
-
Product Insights
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of amyotrophic lateral sclerosis include difficulty breathing, difficulty swallowing, head drop due to weakness of the neck muscles, muscle cramps, speech problems, such as a slow or abnormal speech pattern (slurring of words), voice changes, hoarseness, weight loss. The Amyotrophic Lateral Sclerosis pipeline market research report provides comprehensive information on the therapeutics under development for Amyotrophic Lateral Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type....
-
Product Insights
Tinnitus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Tinnitus pipeline market report provides a comprehensive overview of the therapeutics under development for Tinnitus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Tinnitus and features dormant and discontinued...
-
Product Insights
Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods of unconsciousness or convulsions. Symptoms of epilepsy are repeated seizures, weakness, anxiety, loss of consciousness, and contraction or jerking of body muscles. The Epilepsy Drugs in Development market research report provides an overview of the Epilepsy pipeline landscape. The report provides comprehensive information on the...
-
Product Insights
Eosinophilia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Eosinophilia Global Clinical Trials Review, H2, 2017" provides an overview of Eosinophilia clinical trials scenario. This report provides top line data relating to the clinical trials on Eosinophilia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Hypereosinophilic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Hypereosinophilic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2017" provides an overview of Amyotrophic Lateral Sclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyotrophic Lateral Sclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Nasal Polyps Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, H1, 2016" provides an overview of Nasal Polyps clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Polyps. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...